In systemic sclerosis patients, Bosentan is safe and effective for digital ulcer prevention and it seems to attenuate the development of pulmonary arterial hypertension

Rheumatology (United Kingdom)

Volumn 53, Issue 3, 2014, Pages 570-571

  Romaniello, Antonella ^a   Viola, Giovanna ^a   Salsano, Felice ^b   Rosato, Edoardo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Department of Clinical Medicine   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FINGERS; HUMANS; HYPERTENSION, PULMONARY; SCLERODERMA, SYSTEMIC; SKIN ULCER; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84894349601     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket424     Document Type: Letter

References (8)

1. Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013;65:1953-62.
2. Matucci-Cerinic M, Denton CP, Furst DE et al. Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 2011;70:32-8.
3. Avouac J, Airò P, Meune C et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010;37:2290-8.
4. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
5. Galiè N, Torbicki A, Barst R et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-78.
6. Cutolo M, Sulli A, Secchi ME et al. Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases A future tool for the analysis of microvascular heart involvement? Rheumatology 2006;45(Suppl. 4):43-46.
7. Hachulla E, de Groote P, Gressin V et al. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009;60:1831-9.
8. Rosato E, Molinaro I, Borghese F et al. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension. J Rheumatol 2010;37:2531-9.